Search - tctmd.com

Displaying 661 - 680 of 832

Sort: Relevancy | Date

News Daily News

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

June 07, 2013

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Jason Kahn

May 22, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Daily News

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

Caitlin E. Cox

May 17, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

May 13, 2013

News Daily News

Observational study of surgical vs. transcatheter ASD closure

May 13, 2013

News Daily News

Cognitive Decline Does Not Last Long After CABG

Jason Kahn

May 13, 2013

News Conference News AATS 2013

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

L.A. McKeown

May 07, 2013

News Daily News

Stenting Shows Positive Results in Mesenteric Artery CTO Lesions

Yael L. Maxwell

April 19, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Yael L. Maxwell

April 12, 2013

News Industry News

Medtronic Announces FDA Clearance and First Uses of New Oxygenation System for Adult Cardiac Surgery

April 02, 2013

News Daily News

Position Statement Takes Aim at Alleged Overuse, Promotion of Carotid Artery Stenting

L.A. McKeown

March 28, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

Advertisement

Postmarketing Registry Data Show MitraClip Safe, Effective for MR

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

Patients Who Need Valve-in-Valve After TAVR See Poorer Outcomes

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

Registry Study Explores Potential for TAVR in Low-, Intermediate-Risk Patients

Observational study of surgical vs. transcatheter ASD closure

Cognitive Decline Does Not Last Long After CABG

Promising Early Valve-in-Valve Results Seen in Small Nordic Registry

Stenting Shows Positive Results in Mesenteric Artery CTO Lesions

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Medtronic Announces FDA Clearance and First Uses of New Oxygenation System for Adult Cardiac Surgery

Position Statement Takes Aim at Alleged Overuse, Promotion of Carotid Artery Stenting

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Studies Fail to Tame Controversy Over Off- vs. On-Pump CABG

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content